ADA CERP is a service of the American Dental Association to assist dental professionals in identifying quality providers of continuing dental education. ADA CERP does not approve or endorse individual courses or instructors, nor does it imply acceptance of credit house by boards of dentistry. Concerns or complaints about a CE provider may be directed to the provider or to ADA CERP at www.ada.org/cerp/
Approved PACE Program Provider. FAGD/MAGD credit. Approval does not imply acceptance by a state or provincial board of dentistry, or AGD endorsement. 1/1/2017 to 12/31/2022. ID # 209722.
March 26, 2021 - Expires March 31, 2024
By Dianne Watterson, MBA, RDH
Commercial Supporter: GlaxoSmithKline
Successful treatment of periodontitis involves understanding how the disease progresses and implementing adjuncts for microbial control. Diseases of the oral cavity occur as a combination of microbial activity and the individual host response. Following definitive treatment for periodontitis, therapeutic care continues through supportive periodontal therapy, which differs from regular preventive care.
About the Author
Dianne Watterson, MBA, RDH
Watterson Speaking and Consulting LLC
Lexington, North Carolina